Serum Circ‐FAF1/Circ‐ELP3: A novel potential biomarker for breast cancer diagnosis

• Published in: Journal of clinical laboratory analysis Vol. 35; no. 11; pp. e24008 - n/a
• Main Authors: Omid‐Shafaat, Ramtin, Moayeri, Hassan, Rahimi, Karim, Menbari, Mohammad‐Nazir, Vahabzadeh, Zakaria, Hakhamaneshi, Mohammad‐Saied, Nouri, Bijan, Ghaderi, Bayazid, Abdi, Mohammad
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.11.2021; John Wiley and Sons Inc
• Subjects: Adult; Antigens; Biomarkers; Biomarkers, Tumor - blood; Breast cancer; Breast carcinoma; Breast Neoplasms - blood; Breast Neoplasms - diagnosis; Breast Neoplasms - epidemiology; cancer biomarker; Chemotherapy; Circ‐ELP3; Circ‐FAF1; Diagnosis; diagnostic efficiency; Epidermal growth factor; Estrogens; Female; Gene expression; Humans; Laboratories; Mammography; Medical diagnosis; Medical screening; Metastasis; Middle Aged; RNA polymerase; RNA, Circular - blood; ROC Curve; Tumor markers; Tumors; United States > US; Circ-FAF1; breast cancer; diagnostic efficiency; cancer biomarker; Circ-ELP3

Background Recently, measurement of serum circular RNAs (circRNAs) as a non‐invasive tumor marker has been considered more. We designed the present study to investigate the diagnostic efficiency of serum Circ‐ELP3 and Circ‐FAF1, separately and simultaneously, for diagnosis of patients with breast ca...